Nifty Pharma Today: Index Gains 0.25% in Early Trade

Early-session update, 20 August 2026:Nifty Pharma today rose 66 points, or 0.25%, to 26,379.80 at 10:00:00 AM IST. The index remained above its previous close of 26,313.80, while stock-level participation was positive, with 14 of 20 tracked pharma stocks advancing.

Quick sector takeaways

• Nifty Pharma today traded at 26,379.80, up 66 points or 0.25% from the previous close of 26,313.80.
• The index moved between 26,361.80 and 26,473.20 in the early session after opening at 26,438.30.
• Breadth was constructive: 14 stocks advanced and six declined, with no unchanged stocks among the 20 tracked names.
• Granules India, Glenmark Pharmaceuticals and Laurus Labs led the gainers, while JB Chemicals & Pharmaceuticals, Gland Pharma and Ajanta Pharma were among the notable laggards. Watch whether the index can hold above its previous close as the session develops.

Nifty Pharma today: Early-session view

Nifty Pharma today opened at 26,438.30 and subsequently moved lower from that level, but it continued to trade in positive territory against the previous close. At 26,379.80, the sector index was 66 points higher for the day. This indicates that the opening-session move remained positive on a closing-price basis even as the index was below its opening level.

The early range has been 111.40 points, from the day low of 26,361.80 to the day high of 26,473.20. The last traded level was closer to the day low than the day high, making the progression through the rest of the session important for assessing whether the initial advance broadens or narrows.

Price snapshot

The index high was 159.40 points above the previous close, while the day low was still 48 points above that benchmark. In plain terms, Nifty Pharma has so far stayed above the prior closing level despite easing from its opening price and intraday high.

Sector ranking

Nifty Pharma was selected as the second top losing sector index in the configured sector-index ranking for this update. That ranking describes its relative placement within the selected sector set; the actual index movement remains a gain of 0.25% or 66 points at the stated early-session timestamp. Readers should therefore distinguish the selection label from the live price change displayed by the index.

Within the configured list, the pharma index’s modest positive move trailed several stronger advances, including Nifty IT, Nifty Financial Services and Nifty Bank. The sector’s early-session reading is thus positive in absolute terms, while its ranking places it among the weaker selected sector performances.

Constituent breadth

The breadth picture was constructive. Fourteen of the 20 tracked Nifty Pharma stocks were in the green, while six were in the red and none were unchanged. The advance-decline ratio stood at 2.33, meaning gainers outnumbered decliners by more than two to one.

This breadth is notable because the index’s 0.25% gain was accompanied by positive participation across a majority of its stocks. At the same time, the presence of a few meaningful declines shows that the sector was not moving uniformly. Early-session breadth and index direction were aligned, but individual price moves varied considerably.

Heavyweights versus broader participation

Among the supplied heavyweight names, Cipla Ltd. gained 0.82% to ₹1,433.70, while Dr. Reddy’s Laboratories Ltd. rose 0.39% to ₹1,174.60 and Divi’s Laboratories Ltd. added 0.18% to ₹8,575.00. These advances contrasted with declines in Sun Pharmaceutical Industries Ltd., down 0.25% to ₹1,895.30, and Torrent Pharmaceuticals Ltd., down 0.34% to ₹4,996.00.

The supplied active-stock list also includes Sun Pharmaceutical Industries, Divi’s Laboratories, Torrent Pharmaceuticals, Cipla and Dr. Reddy’s Laboratories. Their mixed performance highlights that broader positive participation was not mirrored by a one-way move across every prominent stock.

Key Nifty Pharma stocks

Biggest positive movers

Granules India led the gainers, rising 1.84% to ₹856.65 and trading at its day high. Glenmark Pharmaceuticals followed with a 1.26% gain to ₹2,274.80, while Laurus Labs advanced 0.95% to ₹1,819.00. Cipla gained 0.82%, and Zydus Lifesciences rose 0.65% to ₹1,111.70. These moves supplied the strongest positive stock-level contributions to the sector’s constructive breadth.

Biggest negative movers

JB Chemicals & Pharmaceuticals Ltd. fell 3.87% to ₹2,408.90, after trading between ₹2,380.00 and ₹2,525.50. Gland Pharma declined 0.99% to ₹2,813.30, Ajanta Pharma slipped 0.51% to ₹3,679.00, and Torrent Pharmaceuticals was down 0.34%. Sun Pharmaceutical Industries edged lower by 0.25%. These declines limited the sector index’s early gain despite the positive breadth.

Stocks to watch next session

Granules India, Glenmark Pharmaceuticals, Cipla, JB Chemicals & Pharmaceuticals, Gland Pharma and Sun Pharmaceutical Industries are key names to monitor. Granules India and Glenmark Pharmaceuticals were the leading gainers in this early snapshot. Cipla was positive among the supplied heavyweight stocks. JB Chemicals & Pharmaceuticals and Gland Pharma saw the sharpest listed declines, while Sun Pharmaceutical Industries remained marginally below its previous close.

The constructive case

The constructive evidence is visible in both the index and breadth readings. Nifty Pharma was above its previous close, 14 of 20 tracked stocks advanced, and the advance-decline ratio was 2.33. Gains in Granules India, Glenmark Pharmaceuticals, Laurus Labs and Cipla show that positive participation extended across multiple stocks rather than being limited to a single name.

The index also held above 26,313.80, its previous close, throughout the reported intraday range. That price behaviour, combined with positive breadth, provides the factual basis for the sector’s constructive early-session tone.

The cautious case

The index was below its opening level of 26,438.30 and below its intraday high of 26,473.20 at the time of the update. It was also trading nearer to the day low of 26,361.80 than the high. This shows that the opening strength had moderated.

Further, the stock-level moves were uneven. JB Chemicals & Pharmaceuticals declined 3.87%, while Gland Pharma, Ajanta Pharma, Torrent Pharmaceuticals and Sun Pharmaceutical Industries also traded lower. The sector’s positive breadth therefore coexisted with pressure in several prominent names.

Univest Insights

The early reading for Nifty Pharma today is one of modest index strength supported by broad participation. A 0.25% gain may appear limited, but the 14-to-six split between advancing and declining stocks gives the move a broader base than the headline percentage alone suggests.

However, the index’s position below its opening price adds an important layer of context. The sector began higher, reached 26,473.20, and then eased to 26,379.80. The next price action will show whether the index can rebuild momentum from above the previous close or whether the intraday pullback extends.

Stock selection remains central within the sector. Granules India and Glenmark Pharmaceuticals displayed the strongest upside among the supplied names, whereas JB Chemicals & Pharmaceuticals stood out on the downside. Meanwhile, the mixed moves in heavyweight stocks underscore that broad breadth does not necessarily mean uniform leadership.

For a wider market context, follow Univest Market View. For traders and investors, the key signal to watch is whether Nifty Pharma today sustains trade above 26,313.80 while its positive breadth remains intact.

Published on 20 August 2026 at 10:04 AM IST

Frequently asked questions

What is Nifty Pharma today?

Nifty Pharma was at 26,379.80 at 10:00:00 AM IST on 20 August 2026, up 66 points or 0.25%.

What was the previous close of Nifty Pharma?

The previous close was 26,313.80.

What were Nifty Pharma’s day high and day low?

The day high was 26,473.20 and the day low was 26,361.80.

How was the breadth in Nifty Pharma?

Fourteen of 20 tracked stocks advanced, six declined and none were unchanged.

Which stocks gained the most in Nifty Pharma?

Granules India rose 1.84%, Glenmark Pharmaceuticals gained 1.26%, and Laurus Labs advanced 0.95%.

Which stocks declined the most in Nifty Pharma?

JB Chemicals & Pharmaceuticals fell 3.87%, Gland Pharma declined 0.99%, and Ajanta Pharma slipped 0.51%.